Start low. Decide as you go.
A lower-dose protocol for people who would rather begin gradually. Prescribed and reviewed by a licensed clinician, with the option to change course.
The same tirzepatide molecule prescribed at a lower dose, compounded with vitamin B12 by a licensed 503A pharmacy. Some clinicians use lower-dose protocols for patients who prefer a more gradual introduction.
Acts on two receptors
Tirzepatide binds both the GIP and GLP-1 receptors, two incretin pathways involved in blood sugar and appetite signalling.
Lower dose by design
The protocol uses smaller amounts of the same medication than standard dosing schedules.
Prescribed and reviewed
Dosing is set by your clinician, started low, and reviewed over time for as long as you are treated.
Yes. You can transfer from another provider and continue on the same or an equivalent dose. This is confirmed during your medical intake so the clinician can prescribe the right dose for you.
Compounded by a licensed 503A pharmacy and tested for potency and purity before it ships.
Confirms the active ingredient is within the specified concentration range.
Confirms the medication is free of microbial contamination (USP 797).
Checks the acid-base balance to minimize irritation on injection.
Screens for bacterial endotoxins below defined threshold limits (USP 85).
Transparent pricing — no membership, no hidden fees. Billed on the schedule you choose; cancel before your next renewal. Prescriptions require clinician approval; if you are not approved, you are not charged.
Start your consultationThis treatment is provided through a subscription that renews at the interval you select unless cancelled before the next renewal date. Cancellation & refund details.
This medication is compounded by a licensed pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act, and may be dispensed only pursuant to a patient-specific prescription issued by a licensed practitioner following a medical evaluation. The FDA does not review or approve compounded medications, including compounded tirzepatide, for safety, effectiveness, or quality.
Compounded tirzepatide is not approved by the FDA for weight management. It is not affiliated with, endorsed or approved by, or intended to replace the FDA-approved products manufactured by Eli Lilly.
Actual product packaging may appear different from any image shown.
There is no FDA-approved dosing for microdose tirzepatide. Your clinician sets a lower dose and a more gradual schedule than standard dosing, based on your intake, and adjusts it over time. Your prescription label lists your exact dose and schedule.
- 01 Complete a medical intake for clinician review.
- 02 A licensed clinician reviews your history and decides if it’s appropriate.
- 03 If approved, your prescription ships to your door.
Compounded tirzepatide is not FDA-approved. Do not use it if you or a family member have had medullary thyroid carcinoma (MTC) or if you have MEN 2. Serious risks include pancreatitis, gallbladder problems, and severe allergic reactions.
Read the full important safety information →
